Literature DB >> 19096723

Causal Vaccine Effects on Binary Postinfection Outcomes.

Michael G Hudgens1, M Elizabeth Halloran.   

Abstract

The effects of vaccine on postinfection outcomes, such as disease, death, and secondary transmission to others, are important scientific and public health aspects of prophylactic vaccination. As a result, evaluation of many vaccine effects condition on being infected. Conditioning on an event that occurs posttreatment (in our case, infection subsequent to assignment to vaccine or control) can result in selection bias. Moreover, because the set of individuals who would become infected if vaccinated is likely not identical to the set of those who would become infected if given control, comparisons that condition on infection do not have a causal interpretation. In this article we consider identifiability and estimation of causal vaccine effects on binary postinfection outcomes. Using the principal stratification framework, we define a postinfection causal vaccine efficacy estimand in individuals who would be infected regardless of treatment assignment. The estimand is shown to be not identifiable under the standard assumptions of the stable unit treatment value, monotonicity, and independence of treatment assignment. Thus selection models are proposed that identify the causal estimand. Closed-form maximum likelihood estimators (MLEs) are then derived under these models, including those assuming maximum possible levels of positive and negative selection bias. These results show the relations between the MLE of the causal estimand and two commonly used estimators for vaccine effects on postinfection outcomes. For example, the usual intent-to-treat estimator is shown to be an upper bound on the postinfection causal vaccine effect provided that the magnitude of protection against infection is not too large. The methods are used to evaluate postinfection vaccine effects in a clinical trial of a rotavirus vaccine candidate and in a field study of a pertussis vaccine. Our results show that pertussis vaccination has a significant causal effect in reducing disease severity.

Entities:  

Year:  2006        PMID: 19096723      PMCID: PMC2603579          DOI: 10.1198/016214505000000970

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  20 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

Review 2.  Lessons for AIDS vaccine development from non-AIDS vaccines.

Authors:  M L Clements-Mann
Journal:  AIDS Res Hum Retroviruses       Date:  1998-10       Impact factor: 2.205

3.  Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials.

Authors:  J R Mascola; B J Mathieson; P M Zack; M C Walker; S B Halstead; D S Burke
Journal:  AIDS Res Hum Retroviruses       Date:  1993-12       Impact factor: 2.205

4.  Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness.

Authors:  Marie-Pierre Préziosi; M Elizabeth Halloran
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

5.  Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines.

Authors:  I M Longini; S Datta; M E Halloran
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-12-15

Review 6.  Design and tests of an HIV vaccine.

Authors:  Andrew McMichael; Matilu Mwau; Tomas Hanke
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

7.  On the analysis of viral load endpoints in HIV vaccine trials.

Authors:  Michael G Hudgens; Antje Hoering; Steven G Self
Journal:  Stat Med       Date:  2003-07-30       Impact factor: 2.373

Review 8.  Human HIV vaccine trials: does antibody-dependent enhancement pose a genuine risk?

Authors:  D S Burke
Journal:  Perspect Biol Med       Date:  1992       Impact factor: 1.416

9.  Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity.

Authors:  Marie-Pierre Préziosi; M Elizabeth Halloran
Journal:  Clin Infect Dis       Date:  2003-08-23       Impact factor: 9.079

10.  Causal inference in infectious diseases.

Authors:  M E Halloran; C J Struchiner
Journal:  Epidemiology       Date:  1995-03       Impact factor: 4.822

View more
  28 in total

1.  Commentary on "Principal stratification - a goal or a tool?" by Judea Pearl.

Authors:  Peter B Gilbert; Michael G Hudgens; Julian Wolfson
Journal:  Int J Biostat       Date:  2011-09-20       Impact factor: 0.968

2.  THE POTENTIAL FOR BIAS IN PRINCIPAL CAUSAL EFFECT ESTIMATION WHEN TREATMENT RECEIVED DEPENDS ON A KEY COVARIATE.

Authors:  Corwin M Zigler; Thomas R Belin
Journal:  Ann Appl Stat       Date:  2011       Impact factor: 2.083

3.  Nonparametric Bounds and Sensitivity Analysis of Treatment Effects.

Authors:  Amy Richardson; Michael G Hudgens; Peter B Gilbert; Jason P Fine
Journal:  Stat Sci       Date:  2014-11       Impact factor: 2.901

4.  Bounding the infectiousness effect in vaccine trials.

Authors:  Tyler J VanderWeele; Eric J Tchetgen Tchetgen
Journal:  Epidemiology       Date:  2011-09       Impact factor: 4.822

5.  A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.

Authors:  Shen-An Hwang; Katarzyna Wilk; Marian L Kruzel; Jeffrey K Actor
Journal:  Vaccine       Date:  2009-04-05       Impact factor: 3.641

6.  Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data.

Authors:  Peter B Gilbert; Yuying Jin
Journal:  Biostatistics       Date:  2009-10-08       Impact factor: 5.899

7.  Principal stratification--uses and limitations.

Authors:  Tyler J Vanderweele
Journal:  Int J Biostat       Date:  2011-07-11       Impact factor: 0.968

8.  Comments: Should Principal Stratification Be Used to Study Mediational Processes?

Authors:  Tyler J VanderWeele
Journal:  J Res Educ Eff       Date:  2012-07

9.  Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis.

Authors:  Bryan E Shepherd; Mary W Redman; Donna P Ankerst
Journal:  J Am Stat Assoc       Date:  2008-12-01       Impact factor: 5.033

10.  Comparing bounds for vaccine effects on infectiousness.

Authors:  M Elizabeth Halloran; Michael G Hudgens
Journal:  Epidemiology       Date:  2012-11       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.